Cytate, a contrast agent, has more fluorescence in cancerous prostate tissue than in normal tissue, researchers have found while working on a project aimed at using imaging instead of biopsies to detect prostate cancer. "Cytate essentially is a smart reagent that attaches to cancerous cells. It is an excellent contrast agent because its absorption and fluorescence spectra line the near-infrared tissue optical window," said one of the researchers.

Full Story:

Related Summaries